Agios Announces Data from Dose-Escalation Phase 1 Study of AG-120 in Patients with IDH1 Mutant Positive Advanced Solid Tumors

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. DOL:CN

Go back to Agios Announces Data from Dose-Escalation Phase 1 Study of AG-120 in Patients with IDH1 Mutant Positive Advanced Solid Tumors
AGIOS PHARM (NASDAQ: AGIO) Delayed: 29.46 +0.74 (2.58%)
Previous Close $28.72    52 Week High $71.49 
Open $28.80    52 Week Low $33.50 
Day High $30.23    P/E N/A 
Day Low $28.51    EPS $-1.18 
Volume 1,141,118